MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway

Background/Aims: MicroRNA-9 (miR-9) is involved in inflammatory reaction in atherosclerosis; however, its function and regulatory mechanisms remain unclear. We aimed to uncover the exact roles of miR-9 and downstream signaling pathways using in vitro human atherosclerosis models. Methods: We used ox...

Full description

Bibliographic Details
Main Authors: Yue Wang, Zhihua Han, Yuqi Fan, Junfeng Zhang, Kan Chen, Lin Gao, Huasu Zeng, Jiatian Cao, Changqian Wang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2017-03-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/470822
_version_ 1819014690686107648
author Yue Wang
Zhihua Han
Yuqi Fan
Junfeng Zhang
Kan Chen
Lin Gao
Huasu Zeng
Jiatian Cao
Changqian Wang
author_facet Yue Wang
Zhihua Han
Yuqi Fan
Junfeng Zhang
Kan Chen
Lin Gao
Huasu Zeng
Jiatian Cao
Changqian Wang
author_sort Yue Wang
collection DOAJ
description Background/Aims: MicroRNA-9 (miR-9) is involved in inflammatory reaction in atherosclerosis; however, its function and regulatory mechanisms remain unclear. We aimed to uncover the exact roles of miR-9 and downstream signaling pathways using in vitro human atherosclerosis models. Methods: We used oxidized low-density lipoprotein (oxLDL)-stimulated human THP-1 derived macrophages, oxLDL-stimulated human primary peripheral blood monocytes and lipopolysaccharides (LPS) or Alum-stimulated human THP-1 derived macrophages as in vitro atherosclerosis inflammation models. Transient transfection of over-expression vectors, small interference RNAs (siRNAs) or antisense oligonucleotides was used to regulate intracellular protein or miR-9 levels. Cell responses and signal transduction were detected by multiple assays including Western blotting, enzyme-linked immunosorbent assay (ELISA) and luciferase reporter assay. Results: MiR-9 inhibited while anti-miR-9 antisense oligonucleotides induced interleukin-1 beta (IL-1β) and NLRP3 inflammasome activation in all in vitro models. Janus kinase 1 (JAK1) and matrix metalloproteinase 13 (MMP-13) were identified as the target genes of miR-9. In oxLDL-stimulated human THP-1 derived macrophages, knockdown of JAK1 by siRNA blocked the phosphorylation of signal transducer and activator of transcription 1 (STAT1) and mimicked the effects of miR-9. In the same model, JAK1 knockdown blocked the phosphorylation of NF-κB p65 in the nuclei and the phosphorylation of NF-κB IκBα in the cytoplasm. Conclusions: Our study demonstrated that miR-9 could inhibit activation of the NLRP3 inflammasome and attenuate atherosclerosis-related inflammation, likely through the JAK1/STAT1 signaling pathway. Therefore, miR-9 may serve as a potential therapeutic target for atherosclerosis.
first_indexed 2024-12-21T02:19:51Z
format Article
id doaj.art-e200e3e2984a4823a48af3ebfd0fabf7
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-21T02:19:51Z
publishDate 2017-03-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-e200e3e2984a4823a48af3ebfd0fabf72022-12-21T19:19:10ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782017-03-014141555157110.1159/000470822470822MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling PathwayYue WangZhihua HanYuqi FanJunfeng ZhangKan ChenLin GaoHuasu ZengJiatian CaoChangqian WangBackground/Aims: MicroRNA-9 (miR-9) is involved in inflammatory reaction in atherosclerosis; however, its function and regulatory mechanisms remain unclear. We aimed to uncover the exact roles of miR-9 and downstream signaling pathways using in vitro human atherosclerosis models. Methods: We used oxidized low-density lipoprotein (oxLDL)-stimulated human THP-1 derived macrophages, oxLDL-stimulated human primary peripheral blood monocytes and lipopolysaccharides (LPS) or Alum-stimulated human THP-1 derived macrophages as in vitro atherosclerosis inflammation models. Transient transfection of over-expression vectors, small interference RNAs (siRNAs) or antisense oligonucleotides was used to regulate intracellular protein or miR-9 levels. Cell responses and signal transduction were detected by multiple assays including Western blotting, enzyme-linked immunosorbent assay (ELISA) and luciferase reporter assay. Results: MiR-9 inhibited while anti-miR-9 antisense oligonucleotides induced interleukin-1 beta (IL-1β) and NLRP3 inflammasome activation in all in vitro models. Janus kinase 1 (JAK1) and matrix metalloproteinase 13 (MMP-13) were identified as the target genes of miR-9. In oxLDL-stimulated human THP-1 derived macrophages, knockdown of JAK1 by siRNA blocked the phosphorylation of signal transducer and activator of transcription 1 (STAT1) and mimicked the effects of miR-9. In the same model, JAK1 knockdown blocked the phosphorylation of NF-κB p65 in the nuclei and the phosphorylation of NF-κB IκBα in the cytoplasm. Conclusions: Our study demonstrated that miR-9 could inhibit activation of the NLRP3 inflammasome and attenuate atherosclerosis-related inflammation, likely through the JAK1/STAT1 signaling pathway. Therefore, miR-9 may serve as a potential therapeutic target for atherosclerosis.http://www.karger.com/Article/FullText/470822NLRP3 inflammasomemiR-9JAK1STAT1Atherosclerosis
spellingShingle Yue Wang
Zhihua Han
Yuqi Fan
Junfeng Zhang
Kan Chen
Lin Gao
Huasu Zeng
Jiatian Cao
Changqian Wang
MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway
Cellular Physiology and Biochemistry
NLRP3 inflammasome
miR-9
JAK1
STAT1
Atherosclerosis
title MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway
title_full MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway
title_fullStr MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway
title_full_unstemmed MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway
title_short MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway
title_sort microrna 9 inhibits nlrp3 inflammasome activation in human atherosclerosis inflammation cell models through the jak1 stat signaling pathway
topic NLRP3 inflammasome
miR-9
JAK1
STAT1
Atherosclerosis
url http://www.karger.com/Article/FullText/470822
work_keys_str_mv AT yuewang microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT zhihuahan microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT yuqifan microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT junfengzhang microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT kanchen microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT lingao microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT huasuzeng microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT jiatiancao microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway
AT changqianwang microrna9inhibitsnlrp3inflammasomeactivationinhumanatherosclerosisinflammationcellmodelsthroughthejak1statsignalingpathway